Regeneron Pharmaceuticals, Inc. (REGN)

CIK 872589 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Regeneron Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Sep 3, 20261440001969223-26-000991
Sep 3, 202640001992352-26-000007
Sep 3, 202640001663758-26-000002
Sep 2, 20261440001969223-26-000988
Sep 2, 20261440001969223-26-000987
Aug 21, 202640001238303-26-000002
Aug 20, 2026N-PX0001104659-26-099230
Aug 20, 202640001697422-26-000002
Aug 12, 202640001681643-26-000006
Aug 12, 202640001992352-26-000005
Aug 10, 20261440001969223-26-000871
Aug 10, 20261440001969223-26-000870
Aug 7, 202613F-HR0001104659-26-092709
Jul 30, 202610-Q0000872589-26-000025
Jul 30, 20268-K0000872589-26-000023
Jul 7, 202640001187443-26-000010
Jul 6, 20268-K0001104659-26-080562
Jul 2, 20261440001968582-26-000693
Jun 17, 20268-K0001104659-26-075127
May 8, 202613F-HR0001104659-26-057922
May 4, 202640001187443-26-000008
Apr 30, 2026SCHEDULE 13G0002100119-26-001017
Apr 29, 20268-K0000872589-26-000014
Apr 29, 202610-Q0000872589-26-000016
Apr 24, 2026DEF 14A0001308179-26-000340